Ghrelin - a key pleiotropic hormone-regulating systemic energy metabolism.

The gastrointestinal peptide hormone ghrelin was discovered in 1999 as the endogenous ligand for the growth hormone secretagogue receptor (GHSR-1a). Since its discovery tremendous research efforts have been directed at unraveling ghrelin's mechanisms of action, revealing that ghrelin is a pleiotropic hormone implicated in myriad of molecular signaling mechanisms. Accordingly, ghrelin is the only known circulating peripheral hormone with the ability to promote a positive energy balance by stimulating food intake while decreasing energy expenditure and body fat utilization. Moreover, beyond its ability to promote the release of growth hormone from the anterior pituitary, ghrelin stimulates gut motility and gastric acid secretion, modulates sleep, taste sensation and behavior, and regulates glucose metabolism. Due to ghrelin's ability to promote body weight gain and adiposity via centrally mediated signaling mechanisms, modulation of the endogenous ghrelin system is considered a promising strategy to treat individuals with pathologically reduced body weight, such as patients with anorexia nervosa or cachexia. The aim of this chapter is to summarize the current knowledge of how ghrelin affects systemic energy metabolism.

[1]  F. Haj,et al.  Vertical sleeve gastrectomy improves glucose and lipid metabolism and delays diabetes onset in UCD-T2DM rats. , 2012, Endocrinology.

[2]  A. Goday,et al.  Effect of Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy on Glucose and Gut Hormones: a Prospective Randomised Trial , 2012, Journal of Gastrointestinal Surgery.

[3]  C. Beglinger,et al.  Metabolic and Hormonal Changes After Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: a Randomized, Prospective Trial , 2012, Obesity Surgery.

[4]  H. Berkenstadt,et al.  Mapping of Ghrelin Gene Expression and Cell Distribution in the Stomach of Morbidly Obese Patients—a Possible Guide for Efficient Sleeve Gastrectomy Construction , 2012, Obesity Surgery.

[5]  Qixing Zhou,et al.  Effects of sleeve gastrectomy surgery with modified jejunoileal bypass on body weight, food intake and metabolic hormone levels of rats , 2011, Journal of Huazhong University of Science and Technology [Medical Sciences].

[6]  Chih‐Yen Chen,et al.  Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. , 2011, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[7]  Y. Iwashita,et al.  A Comparative Study of Gastric Banding and Sleeve Gastrectomy in an Obese Diabetic Rat Model , 2011, Obesity surgery.

[8]  N. Basso,et al.  First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis , 2011, Surgical Endoscopy.

[9]  M. Gazouli,et al.  Long-Term Plasma Ghrelin and Leptin Modulation After Sleeve Gastrectomy in Wistar Rats in Comparison with Gastric Tissue Ghrelin Expression , 2011, Obesity surgery.

[10]  S. Woods,et al.  Ghrelin‐induced adiposity is independent of orexigenic effects , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  S. French,et al.  Metabolic effects of sleeve gastrectomy in female rat model of diet-induced obesity. , 2011, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[12]  Yan Wang,et al.  Effects of Sleeve Gastrectomy in Neonatally Streptozotocin-Induced Diabetic Rats , 2011, PloS one.

[13]  P. Pfluger,et al.  Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia , 2010, Journal of cachexia, sarcopenia and muscle.

[14]  B. Ludvik,et al.  Sleeve Gastrectomy as Sole and Definitive Bariatric Procedure: 5-Year Results for Weight Loss and Ghrelin , 2010, Obesity surgery.

[15]  S. Nicholson,et al.  Development of a sleeve gastrectomy weight loss model in obese Zucker rats. , 2009, The Journal of surgical research.

[16]  Xian-Xian Zhao,et al.  Disturbance of circulating ghrelin and obestatin in chronic heart failure patients especially in those with cachexia , 2009, Peptides.

[17]  M. Nakazato,et al.  Ghrelin and its therapeutic potential for cachectic patients , 2009, Peptides.

[18]  Sanyuan Hu,et al.  Sleeve Gastrectomy Provides a Better Control of Diabetes by Decreasing Ghrelin in the Diabetic Goto–Kakizaki Rats , 2009, Journal of Gastrointestinal Surgery.

[19]  W. Saeger,et al.  Expression of Ghrelin and its Receptor in Human Tissues , 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[20]  K. Wynne,et al.  Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. , 2009, Kidney international.

[21]  J. Elmquist,et al.  Colocalization of ghrelin O-acyltransferase and ghrelin in gastric mucosal cells. , 2009, American journal of physiology. Endocrinology and metabolism.

[22]  P. Pfluger,et al.  GOAT links dietary lipids with the endocrine control of energy balance , 2009, Nature Medicine.

[23]  A. Doğukan,et al.  Ghrelin and Obestatin Levels in End-stage Renal Disease , 2009, The Journal of international medical research.

[24]  B. Estour,et al.  Ghrelin/obestatin ratio in two populations with low bodyweight: Constitutional thinness and anorexia nervosa , 2009, Psychoneuroendocrinology.

[25]  S. Anker,et al.  Cardiac cachexia: a systematic overview. , 2009, Pharmacology & therapeutics.

[26]  Yong Wang,et al.  Plasma Ghrelin Modulation in Gastric Band Operation and Sleeve Gastrectomy , 2009, Obesity surgery.

[27]  M. Mulholland,et al.  Effect of des-acyl ghrelin on adiposity and glucose metabolism. , 2008, Endocrinology.

[28]  J. Goldstein,et al.  Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides , 2008, Proceedings of the National Academy of Sciences.

[29]  D. Ashby,et al.  Gut hormones and the treatment of disease cachexia , 2008, Proceedings of the Nutrition Society.

[30]  D. Witcher,et al.  Ghrelin octanoylation mediated by an orphan lipid transferase , 2008, Proceedings of the National Academy of Sciences.

[31]  T. Alexandrides,et al.  Weight Loss, Appetite Suppression, and Changes in Fasting and Postprandial Ghrelin and Peptide-YY Levels After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: A Prospective, Double Blind Study , 2008, Annals of surgery.

[32]  W. Mitch,et al.  Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. , 2008, Endocrinology.

[33]  H. Amitani,et al.  Obestatin, Acyl Ghrelin, and Des-acyl Ghrelin Responses to an Oral Glucose Tolerance Test in the Restricting Type of Anorexia Nervosa , 2008, Biological Psychiatry.

[34]  M. Tschöp,et al.  Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study , 2008, British Journal of Cancer.

[35]  K. Kangawa,et al.  Structure and function of ghrelin. , 2007, Results and problems in cell differentiation.

[36]  D. Marks,et al.  Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. , 2007, Endocrinology.

[37]  Jose M Garcia,et al.  Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers. , 2007, The oncologist.

[38]  R. Taulli,et al.  Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. , 2007, Molecular biology of the cell.

[39]  S. Anker,et al.  Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary disease. , 2006, Internal medicine.

[40]  P. Pfluger,et al.  Ghrelin action in the brain controls adipocyte metabolism. , 2006, The Journal of clinical investigation.

[41]  Y. Miao,et al.  Ghrelin-containing neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat , 2006, Regulatory Peptides.

[42]  A. Yamanaka,et al.  Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. , 2006, Endocrinology.

[43]  Lian Li,et al.  Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats , 2006, Acta Pharmacologica Sinica.

[44]  I. Shimon,et al.  Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients , 2006, Cancer.

[45]  Chen Chen,et al.  GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure. , 2005, American journal of physiology. Heart and circulatory physiology.

[46]  K. Kangawa,et al.  Treatment of cachexia with ghrelin in patients with COPD. , 2005, Chest.

[47]  B. Ludvik,et al.  Sleeve Gastrectomy and Gastric Banding: Effects on Plasma Ghrelin Levels , 2005, Obesity surgery.

[48]  G. Frost,et al.  Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. , 2005, Journal of the American Society of Nephrology : JASN.

[49]  M. Tschöp,et al.  Postprandial ghrelin release in anorectic patients before and after weight gain , 2005, Psychoneuroendocrinology.

[50]  D. Cummings,et al.  Regulation of ghrelin in physiologic and pathophysiologic states. , 2005, The Journal of nutrition.

[51]  G. Taffet,et al.  Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. , 2005, The Journal of clinical endocrinology and metabolism.

[52]  D. Nutzinger,et al.  Leptin and body weight regulation in patients with anorexia nervosa before and during weight recovery. , 2005, The American journal of clinical nutrition.

[53]  W. Shimizu,et al.  Effects of Ghrelin Administration on Left Ventricular Function, Exercise Capacity, and Muscle Wasting in Patients With Chronic Heart Failure , 2004, Circulation.

[54]  G. Frost,et al.  Ghrelin increases food intake in obese as well as lean subjects , 2004, International Journal of Obesity.

[55]  M. Yamagishi,et al.  Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[56]  M. Tschöp,et al.  Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. , 2004, Endocrine reviews.

[57]  G. Frost,et al.  Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. , 2004, The Journal of clinical endocrinology and metabolism.

[58]  K. Nin,et al.  Short-term secretory regulation of the active form of ghrelin and total ghrelin during an oral glucose tolerance test in patients with anorexia nervosa. , 2004, European journal of endocrinology.

[59]  L. Sussel,et al.  Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[60]  G. Silecchia,et al.  Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[61]  K. Kangawa,et al.  Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure , 2003, Regulatory Peptides.

[62]  K. Kangawa,et al.  Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. , 2003, Current opinion in pharmacology.

[63]  Michael Esterman,et al.  The Distribution and Mechanism of Action of Ghrelin in the CNS Demonstrates a Novel Hypothalamic Circuit Regulating Energy Homeostasis , 2003, Neuron.

[64]  K. Toshinai,et al.  Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. , 2003, Biochemical and biophysical research communications.

[65]  N. Kohno,et al.  Increased plasma ghrelin level in lung cancer cachexia. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[66]  M. Papotti,et al.  Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. , 2003, The American journal of pathology.

[67]  D. Malan,et al.  Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT , 2002, The Journal of cell biology.

[68]  K. Nakao,et al.  Plasma ghrelin and desacyl ghrelin concentrations in renal failure. , 2002, Journal of the American Society of Nephrology : JASN.

[69]  G. Barsh,et al.  Genetic approaches to studying energy balance: perception and integration , 2002, Nature Reviews Genetics.

[70]  M. Papotti,et al.  Ghrelin Expression in Fetal, Infant, and Adult Human Lung , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[71]  W. Langhans Peripheral mechanisms involved with catabolism , 2002, Current opinion in clinical nutrition and metabolic care.

[72]  M. Matsubara,et al.  Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract , 2002, Peptides.

[73]  M. Papotti,et al.  0013-7227/02/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 87(3):1300–1308 Printed in U.S.A. Copyright © 2002 by The Endocrine Society Expression of Ghrelin and of the GH Secretagogue Receptor by Pancreatic Islet Cells and Related , 2022 .

[74]  K. Kangawa,et al.  Weight loss increases circulating levels of ghrelin in human obesity , 2002, Clinical endocrinology.

[75]  G. Frost,et al.  Ghrelin enhances appetite and increases food intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[76]  J. Kamegai,et al.  Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. , 2001, Diabetes.

[77]  M. Tschöp,et al.  Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. , 2001, European journal of endocrinology.

[78]  W. Shimizu,et al.  Elevated Circulating Level of Ghrelin in Cachexia Associated With Chronic Heart Failure: Relationships Between Ghrelin and Anabolic/Catabolic Factors , 2001, Circulation.

[79]  K. Hosoda,et al.  Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[80]  W. Shimizu,et al.  Chronic Administration of Ghrelin Improves Left Ventricular Dysfunction and Attenuates Development of Cardiac Cachexia in Rats With Heart Failure , 2001, Circulation.

[81]  B. Wisse,et al.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. , 2001, Diabetes.

[82]  M. Tschöp,et al.  Post-prandial decrease of circulating human ghrelin levels , 2001, Journal of endocrinological investigation.

[83]  E. Ravussin,et al.  Circulating ghrelin levels are decreased in human obesity. , 2001, Diabetes.

[84]  M. Korbonits,et al.  Presence of ghrelin in normal and adenomatous human pituitary , 2001, Endocrine.

[85]  M. Korbonits,et al.  The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. , 2001, The Journal of clinical endocrinology and metabolism.

[86]  M. Nakazato,et al.  A role for ghrelin in the central regulation of feeding , 2001, Nature.

[87]  J. Kamegai,et al.  Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. , 2000, Endocrinology.

[88]  M. Nakazato,et al.  Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. , 2000, Endocrinology.

[89]  M. Tschöp,et al.  Ghrelin induces adiposity in rodents , 2000, Nature.

[90]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[91]  J. Rømer,et al.  Co-Localization of Growth Hormone Secretagogue Receptor and NPY mRNA in the Arcuate Nucleus of the Rat , 1999, Neuroendocrinology.

[92]  C. Pichard,et al.  Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. , 1997, American journal of respiratory and critical care medicine.

[93]  Roy G. Smith,et al.  Peptidomimetic regulation of growth hormone secretion. , 1997, Endocrine reviews.

[94]  Roy G. Smith,et al.  Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. , 1997, Brain research. Molecular brain research.

[95]  Patrick R. Griffin,et al.  A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release , 1996, Science.

[96]  F. Momany,et al.  Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. , 1980, Endocrinology.

[97]  T. Akamizu,et al.  Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study. , 2009, Endocrine journal.

[98]  B. Herpertz-Dahlmann,et al.  The role of leptin in anorexia nervosa: clinical implications , 2007, Molecular Psychiatry.

[99]  K. Toshinai,et al.  Upregulation of ghrelin expression in cachectic nude mice bearing human melanoma cells. , 2004, Metabolism: clinical and experimental.

[100]  I. Robinson,et al.  Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. , 2004, Endocrinology.

[101]  R. Dardennes,et al.  Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. , 2003, The Journal of clinical endocrinology and metabolism.

[102]  M. Nakazato,et al.  Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. , 2002, The Journal of clinical endocrinology and metabolism.

[103]  F. Momany,et al.  Design, synthesis, and biological activity of peptides which release growth hormone in vitro. , 1981, Endocrinology.